Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Hoffmann-La Roche
Scientific Title
A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti PD-L1 Antibody) in Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone in Patients With Operable Triple Negative Breast Cancer